Back
Viking Therapeutics Stock Predictions
Sponsored
VKTX
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
45
VKTX
Viking Therapeutics
Last Price:
63.15
Seasonality Move:
38.04%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeViking Therapeutics Stock Forecast
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 122.8% based on the past 9 years of stock performance.
- Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Viking Therapeutics Stock Undervalued?
The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 122.8% based on the past 9 years of stock performance.
Viking Therapeutics Stock Rating
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics overpriced?
- Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Viking Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
99.41
52-Week Low:
9.34
Prediction Charts
Market Cap:
7.04B
Price in USD:
63.14
Volume:
28.99M
Beta:
1.32
Technical Analysis
SMA50:
64.43
SMA100:
59.74
SMA200:
59.82
52-Wk Change:
498.44%
Stock Predictions
-
Is Viking Therapeutics stock public?
Yes, Viking Therapeutics is a publicly traded company. -
What is the Viking Therapeutics stock quote today?
The Viking Therapeutics stock price is 63.14 USD today. -
How to buy Viking Therapeutics stock online?
You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-15 | 65.80 | 65.37 | 67.67 | 64.70 |
Oct-16 | 65.82 | 65.85 | 67.31 | 64.91 |
Oct-18 | 65.12 | 65.80 | 66.00 | 64.42 |
Oct-21 | 65.26 | 64.34 | 66.27 | 63.83 |
Oct-22 | 64.25 | 62.03 | 65.04 | 61.60 |
Oct-23 | 61.61 | 60.39 | 62.63 | 60.01 |
Oct-24 | 65.75 | 73.22 | 75.67 | 63.67 |
Oct-25 | 74.00 | 78.03 | 81.04 | 73.15 |
Oct-28 | 79.03 | 74.52 | 81.73 | 74.15 |
Oct-29 | 74.00 | 73.35 | 74.03 | 71.37 |
Oct-30 | 71.00 | 71.75 | 74.81 | 70.10 |
Oct-31 | 71.37 | 72.54 | 74.06 | 70.57 |
Nov-1 | 73.67 | 72.88 | 75.28 | 72.45 |
Nov-4 | 78.30 | 63.14 | 79.10 | 62.80 |
Viking Therapeutics Earnings
Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics Forecast Revenue Growth
Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.